United States · FDA National Drug Code directory
Fexofenadine HCl and Pseudoephedrine HCI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0363-1606_22a37aee-5811-616b-a794-4c24bd940d73
- Product NDC
- 0363-1606
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Fexofenadine HCl and Pseudoephedrine HCI
- Labeler
- Walgreens Company
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190916
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 60 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (0363-1606-20) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0363-1606-20
- 6 BLISTER PACK in 1 CARTON (0363-1606-30) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0363-1606-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →